RVAC Medicines
PrivateLast Round
Series B
Apr 26, 2022
Total Funding Raised
$140M
Company Overview
RVAC Medicines is a biotechnology company that develops an mRNA platform to build a diverse pipeline of innovative vaccines and therapeutics to address unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RVAC Medicines Comparables
Compare RVAC Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innorna | 88% | |
| Immorna Biotherapeutics | 83% | |
| Strand Therapeutics | 79% |
RVAC Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 26, 2022 |
RVAC Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Group | Series B |
| EDBI | Series B |
| Pavilion Capital | Series B |
| GS Holdings | Series B |
RVAC Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RVAC Medicines's valuation, stock price, and market status.
Is RVAC Medicines a public or private company?
RVAC Medicines is a private company.
What is the current stock price of RVAC Medicines?
RVAC Medicines is a private company with no public stock price. No recent secondary market data is available.
How much is RVAC Medicines worth (valuation)?
Valuation information for RVAC Medicines is not publicly available.
Can I buy RVAC Medicines stock?
RVAC Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RVAC Medicines's last funding round?
RVAC Medicines's most recent funding round was Series B on April 26, 2022.
Who are the main investors in RVAC Medicines?
Key investors in RVAC Medicines include CBC Group.
Will RVAC Medicines IPO soon?
No public IPO plans have been announced for RVAC Medicines.
How can I track RVAC Medicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RVAC Medicines's secondary market activity and sign up for updates.